AUPH Aurinia Pharmaceuticals Inc Total Asset Value of Company
This price trend visualization of Aurinia Pharmaceuticals (AUPH) total assets on the GURU.Markets platform, with a value of 676.58, demonstrates a company utilizing an asset-light model by outsourcing drug manufacturing to Lonza plants. The business is currently focused on the market launch of Lupkynis and adapting the drug for new diagnoses. The core strategy is driven by the ambition to establish the first oral therapy for lupus nephritis as the primary standard of care.
Analytical breakdowns and data insights for company Aurinia Pharma (AUPH)
- stock price and consensus target price:
- market capitalization data:
- issuer book value statistics:
- debt burden and liquidity indicators:
All Debt to Shareholders' Equity Ratio Aurinia Pharmaceuticals|AUPH - Long-Term Debt to Equity|Short-Term Debt to Equity Ratio Aurinia Corp|AUPH - Company Aggregate Debts|Debts to Book Capitalization Aurinia Corp|AUPH - Company Long-Term Liabilities|Company Short-Term Loans and Borrowings Aurinia Pharmaceuticals|Interim Coverage Ratio auriniapharma.com
- net income and valuation multiples indicators:
Fundamental valuation:Aurinia Pharmaceuticals
Total assets represent the sum of equity and debt, defining the company's resource base for profit generation. By monitoring assets via ROA, an investor can track the dynamics of the asset portfolio as mathematically reconstructed through profitability, which is critically important for Aurinia Pharmaceuticals (AUPH) during the global scaling of its immunology drug sales and expansion into international markets.
Key competitors
argenx.com - Aggregate Asset Value|Aggregate Company Assets BioNTech|Abivax - Total Asset Value of Company|Company Total Assets ADMA|PTGX (Protagonist Corp) - Aggregate Asset Value|Company Total Assets IMVT (Immunovant, Inc.)|Company Total Assets kiniksa.com KNSA|GRFS - Aggregate Company Assets|Aggregate Asset Value ADPT (Adaptive Biotech)|Celldex (CLDX) - Aggregate Company Assets|Cumulative Company Assets BioCryst Corp|VERA (Vera Therapeutics, Inc.) - Company Total Assets|Company Total Assets dianthustx.com|Cumulative Company Assets PHVS (Pharvaris)|ABCL (AbCellera Biologics) - Aggregate Asset Value|Company Total Assets TRML (Tourmaline Corp)|Company Total Asset Base Precigen Corp (PGEN)|PHAR - Aggregate Company Assets|nektar.com (NKTR) - Cumulative Company Assets|Upstream Bio (UPB) - Aggregate Company Assets|Cumulative Company Assets Zenas Bio|Cumulative Company Assets IMNM|Company Total Assets Gossamer Bio Corp.|Aggregate Company Assets KalVista Pharmaceuticals (KALV)|septerna.com - Total Business Assets|Company Total Assets PVLA (Pieris Pharmaceuticals, Inc.)|Savara Inc (SVRA) - Company Assets|Rigel Pharmaceuticals Inc - Company Total Assets|ANAB - Company Total Assets|ATXS (Astria Therapeutics) - Cumulative Company Assets|engene.com (ENGN) - Company Total Assets|Aggregate Company Assets RAPT Therapeutics|JBIO: Aggregate Asset Value|Company Total Assets ACRS|Company Total Asset Base Kyverna Therapeutics, Inc|Aggregate Company Assets Tiziana Life Sciences TLSA|CABA: Total Business Assets|Ventyx Biosciences, Inc. - Company Total Assets|Company Total Asset Base Theratechnologies, Inc. THTX|AVTX: Company Total Assets|Eledon Pharmaceuticals, Inc (ELDN) - Company Total Assets|Cumulative Company Assets AGEN|CLYM: Aggregate Asset Value|Aggregate Company Assets Zura Bio (ZURA)|ATYR: Total Asset Value of Company|Company Total Assets ADAG (Adagene Inc.)|Aggregate Asset Value IMA|Shattuck Therapeutics - Company Total Assets|EQ - Company Total Assets|connectbiopharm.com (CNTB) - Aggregate Company Assets|Immunic - Aggregate Asset Value|Aggregate Company Assets Atara Biotherapeutics, Inc.|Cumulative Company Assets InflaRx GmbH (IFRX)|Company Total Assets XFOR|Company Total Assets adicetbio.com (ACET)|Company Total Assets CELU (Celularity)|INMB - Cumulative Company Assets|Barinthus Bio - Company Total Assets|Company Assets Kezar Life Sciences Inc|SABS (SAB Biotherapeutics) - Cumulative Company Assets|akaritx.com (AKTX) - Company Total Assets|Cumulative Company Assets ENLV|QTTB (Q32 Bio Corp) - Aggregate Business Assets|Company Total Assets GOVX|Company Total Asset Base Edesa Biotech Corp|Company Total Assets IBIO (iBio, Inc.)|CARM - Cumulative Company Assets|XTL Biopharmaceuticals Ltd. - Company Total Assets|BOLT - Company Total Assets|hcwbiologics.com (HCWB) - Aggregate Company Assets|APVO (Aptevo Therapeutics Inc.) - Aggregate Company Assets|Aggregate Company Assets AIM ImmunoTech Inc.|Aditxt Corp (ADTX) - Company Total Asset Base|Company Total Assets GRI|Company Total Assets XORTX Therapeutics Inc (XRTX)|ReShape Lifesciences - Cumulative Company Assets|Company Total Assets Revelation Biosciences Corp REVB|INDP - Aggregate Company Assets|Total Asset Value of Company SCNI|CALI: Company Total Assets|Affimed N.V. - Aggregate Asset Value|Aggregate Company Assets Allakos Inc|HOOKIPA - Total Asset Value of Company|Company Total Assets IGMS|ITOS (iteostherapeutics.com) - Aggregate Asset Value|Company Total Assets OCEA (Ocean Biomedical)|Company Total Assets TC BioPharm (Holdings) Plc TCBP|THRD - Aggregate Company Assets